Press releases

Creates a global leader in cardiovascular devices and one of the largest medical technology companies in the world

Transaction scheduled to close tomorrow

"We are very pleased that we achieved record company sales for the quarter," said Jim Tobin, President and Chief Executive Officer

New study seeks to define potential of Precision™ system to treat large population of U.S. migraine sufferers who don't respond adequately to current therapies

Company must also receive antitrust approval from the U.S. Federal Trade Commission (FTC) before it can close the Guidant transaction